Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABIGATRAN ETEXILATE for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where DABIGATRAN ETEXILATE was used for Off label use.

Most Reported Side Effects for DABIGATRAN ETEXILATE

Side Effect Reports % Deaths Hosp.
Gastrointestinal haemorrhage 4,081 11.0% 1,013 3,611
Cerebrovascular accident 2,175 5.9% 216 1,192
Fall 1,786 4.8% 315 1,312
Ischaemic stroke 1,581 4.3% 147 1,054
Anaemia 1,412 3.8% 240 1,244
Haemorrhage 1,324 3.6% 397 735
Death 1,025 2.8% 1,025 284
Rectal haemorrhage 964 2.6% 200 751
Cerebral haemorrhage 946 2.6% 483 633
Upper gastrointestinal haemorrhage 861 2.3% 205 794
Atrial fibrillation 858 2.3% 79 538
Off label use 840 2.3% 73 334
Acute kidney injury 805 2.2% 218 658
Lower gastrointestinal haemorrhage 757 2.0% 141 702
Procoagulant therapy 737 2.0% 4 621

Other Indications for DABIGATRAN ETEXILATE

Atrial fibrillation (20,492) Product used for unknown indication (11,730) Cerebrovascular accident prophylaxis (2,567) Thrombosis prophylaxis (1,113) Anticoagulant therapy (780) Deep vein thrombosis (668) Pulmonary embolism (527) Cerebrovascular accident (337) Thrombosis (229) Atrial flutter (209)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) CERTOLIZUMAB PEGOL (2,256) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033)

Related Pages

DABIGATRAN ETEXILATE Full Profile All Off label use Drugs DABIGATRAN ETEXILATE Demographics DABIGATRAN ETEXILATE Timeline